These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2570401)

  • 21. A missense mutation in the dystrophin gene in a Duchenne muscular dystrophy patient.
    Prior TW; Papp AC; Snyder PJ; Burghes AH; Bartolo C; Sedra MS; Western LM; Mendell JR
    Nat Genet; 1993 Aug; 4(4):357-60. PubMed ID: 8401582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Detection of dystrophin gene mutation carrier state].
    Bisko M; Zimowski JG; Fidziańska E; Badurska B; Fidziańska A; Hausmanowa-Petrusewicz I; Zaremba J
    Neurol Neurochir Pol; 1996; 30(2):193-9; quiz 200. PubMed ID: 8756246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of a CACA repeat polymorphism in genotype assignments in Duchenne/Becker muscular dystrophy.
    Miller M; Boehm C; Cotton M; Kazazian HH
    Am J Med Genet; 1992 Nov; 44(4):473-6. PubMed ID: 1442890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A MaeIII polymorphism near the dystrophin gene promoter by restriction of amplified DNA.
    Roberts RG; Bobrow M; Bentley DR
    Nucleic Acids Res; 1990 Mar; 18(5):1315. PubMed ID: 1969623
    [No Abstract]   [Full Text] [Related]  

  • 25. DNA amplification of a further exon of Duchenne muscular dystrophy locus increase possibilities for deletion screening.
    Speer A; Rosenthal A; Billwitz H; Hanke R; Forrest SM; Love D; Davies KE; Coutelle C
    Nucleic Acids Res; 1989 Jun; 17(12):4892. PubMed ID: 2783234
    [No Abstract]   [Full Text] [Related]  

  • 26. Southern blot and PCR analyses of dystrophin gene deletions in Japanese patients with Duchenne muscular dystrophy.
    Nakajima T; Matsuo M; Nakamura H; Fujiwara Y
    Kobe J Med Sci; 1991 Feb; 37(1):21-33. PubMed ID: 1921260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Base substitutions in the human dystrophin gene: detection by using the single-strand conformation polymorphism (SSCP) technique.
    Tuffery S; Moine P; Demaille J; Claustres M
    Hum Mutat; 1993; 2(5):368-74. PubMed ID: 8257990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A polymorphic CACA repeat in the 3' untranslated region of dystrophin.
    Beggs AH; Kunkel LM
    Nucleic Acids Res; 1990 Apr; 18(7):1931. PubMed ID: 1970874
    [No Abstract]   [Full Text] [Related]  

  • 29. [Microsatellite analysis of Duchenne muscular dystrophy].
    Fujishita S; Shibuya N
    Nihon Rinsho; 1997 Dec; 55(12):3131-6. PubMed ID: 9436423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linkage disequilibria among (CA)n polymorphisms in the human dystrophin gene and their implications in carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophies.
    Chakraborty R; Zhong Y; de Andrade M; Clemens PR; Fenwick RG; Caskey CT
    Genomics; 1994 Jun; 21(3):567-70. PubMed ID: 7959733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new intragenic polymorphism detected by the single-strand conformation polymorphism (SSCP) assay in the dystrophin gene.
    Tuffery S; Demaille J; Claustress M
    Hum Mutat; 1992; 1(3):221-3. PubMed ID: 1301928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of three novel mutations in the dystrophin gene detected by the heteroduplex/SSCA screening procedure. Mutations in brief no. 222. Online.
    Dubourg C; Odent S; Fergelot P; Le Gall JY; David V; Blayau M
    Hum Mutat; 1999; 13(2):173. PubMed ID: 10094565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of DNA analysis in the prevention of progressive muscular dystrophies].
    Kádasi L; Ferák V; Thurzová M; Kvasnicová M
    Bratisl Lek Listy; 1988 Nov; 89(11):828-34. PubMed ID: 2904832
    [No Abstract]   [Full Text] [Related]  

  • 34. Case of the month: germline mosaicism in carriers of Duchenne muscular dystrophy.
    Prior TW; Papp AC; Snyder PJ; Mendell JR
    Muscle Nerve; 1992 Aug; 15(8):960-3. PubMed ID: 1353862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic markers and testing.
    Burton BK
    Med Sect Proc; 1989; ():45-57. PubMed ID: 2577094
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter.
    Nishio H; Takeshima Y; Narita N; Yanagawa H; Suzuki Y; Ishikawa Y; Ishikawa Y; Minami R; Nakamura H; Matsuo M
    J Clin Invest; 1994 Sep; 94(3):1037-42. PubMed ID: 8083345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular diagnosis of Duchenne muscular dystrophy by use of a conformational polymorphism in the absence of DNA from an affected boy.
    Tuffery S; Moine P; Sarda P; Lefort G; Boulot P; Demaille J; Claustres M
    Genet Couns; 1994; 5(2):183-5. PubMed ID: 7917130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Polymerase chain reaction, cold probes and clinical diagnosis].
    Haras D; Amoros JP
    Sante; 1994; 4(1):43-52. PubMed ID: 7909267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. X-linked muscular dystrophies: studies through functional assay and DNA polymorphisms.
    Romeo G; Rocchi M; Roncuzzi L; Ferlini A; Nobile C; Rugolo M
    Adv Neurol; 1988; 48():31-6. PubMed ID: 2891257
    [No Abstract]   [Full Text] [Related]  

  • 40. Point mutations in the dystrophin gene.
    Roberts RG; Bobrow M; Bentley DR
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2331-5. PubMed ID: 1549596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.